Form 8-K - Current report:
SEC Accession No. 0001193125-25-125833
Filing Date
2025-05-23
Accepted
2025-05-23 16:05:25
Documents
13
Period of Report
2025-05-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d95113d8k.htm   iXBRL 8-K 36349
2 EX-3.1 d95113dex31.htm EX-3.1 6118
  Complete submission text file 0001193125-25-125833.txt   166965

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vor-20250522.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20250522_lab.xml EX-101.LAB 19482
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20250522_pre.xml EX-101.PRE 12144
15 EXTRACTED XBRL INSTANCE DOCUMENT d95113d8k_htm.xml XML 3974
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 25982131
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)